IRIS - Res&Arch Institutional Research Information System - Research & Archive

BASILEO, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.092
AS - Asia 1.397
EU - Europa 1.369
SA - Sud America 216
AF - Africa 11
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.995
SG - Singapore 558
IE - Irlanda 324
UA - Ucraina 301
HK - Hong Kong 243
CN - Cina 232
VN - Vietnam 206
BR - Brasile 191
RU - Federazione Russa 159
DE - Germania 133
IT - Italia 124
FI - Finlandia 109
CA - Canada 78
SE - Svezia 62
GB - Regno Unito 45
KR - Corea 42
TR - Turchia 42
BE - Belgio 25
FR - Francia 21
MX - Messico 16
LB - Libano 14
IN - India 12
PL - Polonia 12
AT - Austria 10
JP - Giappone 10
CH - Svizzera 9
AR - Argentina 8
BD - Bangladesh 8
ES - Italia 8
NL - Olanda 7
CZ - Repubblica Ceca 6
LT - Lituania 6
CL - Cile 5
EC - Ecuador 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
IQ - Iraq 4
MY - Malesia 3
PE - Perù 3
AU - Australia 2
CO - Colombia 2
GR - Grecia 2
ID - Indonesia 2
JO - Giordania 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PK - Pakistan 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
DZ - Algeria 1
EU - Europa 1
GH - Ghana 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 5.089
Salva come PNG Salva come JPEG
Città #
Chandler 397
Singapore 371
Dublin 324
Hong Kong 243
Jacksonville 166
San Mateo 166
Dong Ket 165
Ashburn 109
Boardman 82
Santa Clara 80
Beijing 76
Medford 71
Princeton 71
Ann Arbor 70
Ottawa 60
Munich 56
Andover 49
Moscow 49
Wilmington 42
Izmir 37
Helsinki 27
São Paulo 27
Seoul 26
Los Angeles 23
New York 23
Perugia 22
Saint Petersburg 21
Altamura 16
Brussels 16
Ho Chi Minh City 16
Norwalk 15
Dongjak-gu 14
Genoa 13
Lawrence 13
Brooklyn 12
Des Moines 12
Orem 12
Columbus 11
Falls Church 11
London 11
Turku 11
Tokyo 10
Boston 9
Chicago 9
Denver 9
Houston 9
Montreal 9
Redwood City 9
Hanoi 8
Mexico City 8
Frankfurt am Main 7
Piscataway 7
Warsaw 7
Longueville 6
Porto Alegre 5
Redmond 5
Sorocaba 5
Stockholm 5
Ankara 4
Atlanta 4
Belo Horizonte 4
Bologna 4
Dallas 4
Nuremberg 4
Rio de Janeiro 4
San Francisco 4
Seattle 4
Zhengzhou 4
Amsterdam 3
Bastia umbra 3
Belfiore 3
Biên Hòa 3
Brasília 3
Buffalo 3
Calgary 3
Carapicuíba 3
Charlotte 3
Chennai 3
Den Haag 3
Düsseldorf 3
Fortaleza 3
Guangzhou 3
Haiphong 3
Heusden 3
Itaquaquecetuba 3
Johannesburg 3
Kuala Lumpur 3
Lauterbourg 3
Manchester 3
Milan 3
Padova 3
Poplar 3
Portsmouth 3
Pozzallo 3
Rome 3
Salvador 3
Santiago 3
Secaucus 3
Shijiazhuang 3
Sona 3
Totale 3.299
Salva come PNG Salva come JPEG
Nome #
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 131
Diagnosi molecolare di sepsi: impiego della PCR Real-Time 118
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 109
Annually repeated influenza vaccination and humoral response in elderly volunteers. 105
Influenza vaccination in patients on long-term anticoagulant therapy. 102
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 101
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 100
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 96
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 96
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 95
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 95
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 93
Influenza vaccination in patients on long-term anticoagulant therapy 93
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 92
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 91
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 90
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 89
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 89
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 88
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 87
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 86
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 86
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 85
The good use of plasma. A critical analysis of five international guidelines. 84
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 83
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 83
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 82
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 82
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 80
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 79
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 78
Computer assisted vka monitoring with point of care device by general practitioners. 77
Comparison of the BD Phoenix system with the cefoxitin disk diffusion test for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci. 77
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 76
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 76
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 75
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 72
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 72
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 69
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 67
Utilizzo di AGREE per l’analisi delle linee guida (LG) internazionali sul buon uso del plasma. 66
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 65
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 64
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 64
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 64
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 62
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 62
AUDIT OF THE CLINICAL USE OF FRESH-FROZEN PLASMA IN UMBRIA: STUDY DESIGN AND RESULTS. 57
Fresh Frozen Plasma Transfusion Practice: A Regional Benchmark Study. 56
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 56
CLINICAL AUDIT OF THE USE OF FRESH FROZEN PLASMA IN UMBRIA. 56
Sorveglianza delle paralisi flaccide acute nella regione Umbria 56
Preliminary survey of human intestinal parasitosis in a Peruvian Andean zone 55
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 54
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 54
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 53
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 53
COMPUTER ASSISTED VKA MONITORING WITH POINT OF CARE DEVICE BY GENERAL PRACTITIONERS. 52
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 52
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 52
Il processo di validazione clinica di un algoritmo computerizzato per il monitoraggio della TAO 51
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 51
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 51
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 50
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 50
The good use of plasma. A critical analysis of five international guidelines. 48
INTERNATIONAL GUIDELINES ABOUT CLINICAL USE OF FRESH FROZEN PLASMA: A CRITICAL APPRAISAL. 46
Sondaggio conoscitivo coproparassitologico in una zona andina della Cordillera Blanca, Peru'. 43
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 43
INHIBITOR DEVELOPMENT IN MILD HAEMOPHILIA A: COULD INFLUENZA VACCINATION HAVE BEEN THE TRIGGER? 40
PROSPECTIVE ASSESSMENT OF CLINICAL ENDPOINTS OF VKA TREATMENT IN A PRIMARY CARE COMPUTER ASSISTED MANAGEMENT MODEL 38
Totale 5.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021354 0 0 0 0 0 14 56 4 50 11 50 169
2021/2022512 5 101 1 12 22 8 6 213 6 10 57 71
2022/20231.072 75 102 9 102 106 111 0 63 442 5 36 21
2023/2024438 28 42 28 9 3 0 141 20 39 5 63 60
2024/2025966 11 90 32 54 161 44 49 24 177 69 171 84
2025/2026958 144 130 51 234 281 118 0 0 0 0 0 0
Totale 5.193